Sadakatsu Ikeda is a board-certified medical oncologist who has rich experience in precision cancer medicine and immune therapy. He is actively involved in clinical research, including clinical trials.

Educated at Hokkaido University School of Medicine, Sapporo, Japan, he started his residency at St Luke’s International Hospital, Tokyo, Japan followed by research fellow at Children’s Hospital Boston/Harvard Medical School. He underwent medicine residency at Beth Israel Medical Center and hematology/oncology fellowship at the University of Michigan, USA.

Prior to his position at Institute of Science Tokyo Hospital, formerly Tokyo Medical and Dental University, he was Assistant Clinical Professor, Department of Medicine, Division of Hematology at the University of California, San Diego, USA.